Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Mol Cell. 2011 Oct 21;44(2):290-303. doi: 10.1016/j.molcel.2011.08.030.
The activities of both mTORC1 and mTORC2 are negatively regulated by their endogenous inhibitor, DEPTOR. As such, the abundance of DEPTOR is a critical determinant in the activity status of the mTOR network. DEPTOR stability is governed by the 26S-proteasome through a largely unknown mechanism. Here we describe an mTOR-dependent phosphorylation-driven pathway for DEPTOR destruction via SCF(βTrCP). DEPTOR phosphorylation by mTOR in response to growth signals, and in collaboration with casein kinase I (CKI), generates a phosphodegron that binds βTrCP. Failure to degrade DEPTOR through either degron mutation or βTrCP depletion leads to reduced mTOR activity, reduced S6 kinase activity, and activation of autophagy to reduce cell growth. This work expands the current understanding of mTOR regulation by revealing a positive feedback loop involving mTOR and CKI-dependent turnover of its inhibitor, DEPTOR, suggesting that misregulation of the DEPTOR destruction pathway might contribute to aberrant activation of mTOR in disease.
mTORC1 和 mTORC2 的活性都受到其内源性抑制剂 DEPTOR 的负调控。因此,DEPTOR 的丰度是决定 mTOR 网络活性状态的关键因素。DEPTOR 的稳定性受 26S 蛋白酶体通过一个很大程度上未知的机制调控。在这里,我们描述了一种通过 SCF(βTrCP)驱动的、依赖于 mTOR 的磷酸化途径来破坏 DEPTOR。生长信号刺激下 mTOR 对 DEPTOR 的磷酸化作用,与酪蛋白激酶 I(CKI)协同作用,生成一个与βTrCP 结合的磷酸化降解结构域。如果通过降解结构域突变或βTrCP 耗竭阻止 DEPTOR 的降解,会导致 mTOR 活性降低、S6 激酶活性降低以及自噬激活以减少细胞生长。这项工作通过揭示一个涉及 mTOR 和 CKI 依赖性 DEPTOR 抑制剂周转的正反馈回路,扩展了我们对 mTOR 调控的理解,表明 DEPTOR 破坏途径的失调可能导致疾病中 mTOR 的异常激活。